| Alexion Pharmaceuticals, Inc. | 113,56 / +0,91% |
| Datum/Vreme | 17.01. / 20:19 |
| Promena / Promena(%) | 1,02 / +0,91% |
| Tražnja | - |
| Ponuda | - |
| Cena na otvaranju | 113,14 |
| Prethodno zatvaranje | 112,54 |
| Najviša cena | 114,34 |
| Najniža | 112,51 |
| Obim [USD] | 4.005.096,25 |
| Obim [Jedinice] | 35.348 |
| Dogovorena cena | 398 |
| ISIN | US0153511094 |
| Simbol | ALXN |
| Berza | IEX |
| Vrsta | Stock |
Druge berze
| Berza | Poslednja cena | Obim | |
|---|---|---|---|
| NASDAQ | 113,5200 |  |
696.674 |
| Cboe US | 113,56 | |
80.849 |
| IEX | 113,56 | |
35.348 |
| TradeGate | 102,640 |  |
473 |
| London Inter.. | 113,01 | |
385 |
| München | 101,22 | |
1 |
| Düsseldorf | 100,64 | |
0 |
| Frankfurt | 102,3400 | |
0 |
| Xetra | 102,34 | |
0 |
| Berlin | 100,74 | |
0 |
| Vienna Globa.. | 102,44 | |
0 |
| gettex | 102,460 | |
|
| Lang & Schwa.. | 102,24 | |
|
| Stuttgart | 101,520 | |
|
| Mexico | 2.155,00 | |
2.046 |
Vesti
- Fortress Biotech Announces Rare Pediatric Disease Designation for CUTX-101 for the Treatment of Menkes Disease
16.01.2020 / 14:30 - GlobeNewswire - Fortress Biotech Announces Exclusive Worldwide License Agreement With AstraZeneca and Cincinnati Children’s Hospital Medical Center to Develop a Novel Treatment for Select CNS Disorders
23.12.2019 / 14:30 - GlobeNewswire - Achillion Shareholders Approve Agreement to be Acquired by Alexion
19.12.2019 / 15:24 - GlobeNewswire - IDG Honors Premier Organizations and Rising IT Leaders Driving Digital Innovation
16.12.2019 / 15:59 - GlobeNewswire - Merus Announces Chief Executive Officer Transition
16.12.2019 / 14:30 - GlobeNewswire
Realno vremeKliknite na 
da aktivirate push kvote.
da aktivirate push kvote.